Biochemical markers of bone turnover in lactating and nonlactating postpartum women
- PMID: 7608281
- DOI: 10.1210/jcem.80.7.7608281
Biochemical markers of bone turnover in lactating and nonlactating postpartum women
Abstract
We measured two bone-formation markers, osteocalcin and bone-specific alkaline phosphatase, and one bone-resorption marker, N-telopeptide, in a longitudinal study in order to describe levels of these markers in lactating and nonlactating women after parturition. This 18-month postpartum period included an initial 6 months in which a 5% short-term bone loss occurred at both spine and femoral neck among breast-feeding women. The second part of the 18-month period was characterized by bone recovery among women who had lost bone. These bone-change characteristics provided an opportunity to evaluate the performance of biochemical markers during both bone loss and recovery and to identify environmental exposures during lactation associated with bone turnover. The eligible population comprised 115 women whose bone-turnover markers were measured at 2 weeks (baseline) and at 2, 4, 6, 12, and 18 months after parturition. Participants reported reproductive characteristics, diet, physical activity, use of medications, and infant-feeding practices at each contact. Women were grouped according to lactation duration: 0-1 months, 2-5 months, and 6 months or more. Women who breast-fed for at least 6 months had significantly different levels of all three bone-turnover markers compared with the levels in bottle-feeding controls, which were indicative of substantially increased bone turnover. Factors that predicted the difference in biochemical markers from baseline to 6-month values by regression analysis were lactation of 2-6 months duration and lactation for 6 months or more. Dietary calcium intake, physical activity level, and body size did not explain the differences in the change from the baseline level to the 6-month level, a period of time that corresponded with bone loss in the lactating women. Factors that predicted the differences in bone-turnover markers between 6 and 18 months (the time of bone-mass recovery) were lactation status and number of months to resumption of menses. By the 18-month observation, there was no difference in the mean values for the measured bone-turnover markers among the three lactation groups. This suggests that menstrual activity, rather than diet or physical activity, is the primary factor in bone-mass recovery after the bone loss of lactation.
Similar articles
-
Bone turnover markers during lactation, postpartum amenorrhea and resumption of menses.Osteoporos Int. 2003 Apr;14(2):103-9. doi: 10.1007/s00198-002-1320-0. Epub 2003 Feb 12. Osteoporos Int. 2003. PMID: 12730783
-
Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.J Bone Miner Res. 1998 Sep;13(9):1431-8. doi: 10.1359/jbmr.1998.13.9.1431. J Bone Miner Res. 1998. PMID: 9738515 Clinical Trial.
-
Biochemical markers of bone turnover in the dairy cow during lactation and the dry period.Res Vet Sci. 2005 Feb;78(1):17-9. doi: 10.1016/j.rvsc.2004.05.002. Res Vet Sci. 2005. PMID: 15500834
-
[Biochemical markers of bone remodeling: recent data of their applications in managing postmenopausal osteoporosis].Tunis Med. 2006 Nov;84(11):751-7. Tunis Med. 2006. PMID: 17294906 Review. French.
-
Body composition changes during lactation are highly variable among women.J Nutr. 1998 Feb;128(2 Suppl):381S-385S. doi: 10.1093/jn/128.2.381S. J Nutr. 1998. PMID: 9478031 Review.
Cited by
-
Grand multiparity associations with low bone mineral density and degraded trabecular bone pattern.Bone Rep. 2021 Apr 22;14:101071. doi: 10.1016/j.bonr.2021.101071. eCollection 2021 Jun. Bone Rep. 2021. PMID: 33997148 Free PMC article.
-
Bone turnover and density in healthy women during breastfeeding and after weaning.Osteoporos Int. 1996;6(2):153-9. doi: 10.1007/BF01623940. Osteoporos Int. 1996. PMID: 8704355
-
OPG Treatment Prevents Bone Loss During Lactation But Does Not Affect Milk Production or Maternal Calcium Metabolism.Endocrinology. 2015 Aug;156(8):2762-73. doi: 10.1210/en.2015-1232. Epub 2015 May 11. Endocrinology. 2015. PMID: 25961842 Free PMC article.
-
25-Hydroxyvitamin D profiles and maternal bone mass during pregnancy and lactation in Japanese women.J Bone Miner Metab. 2020 Jan;38(1):99-108. doi: 10.1007/s00774-019-01032-w. Epub 2019 Aug 20. J Bone Miner Metab. 2020. PMID: 31432265
-
Bone fragility and osteoporosis in children and young adults.J Endocrinol Invest. 2024 Feb;47(2):285-298. doi: 10.1007/s40618-023-02179-0. Epub 2023 Sep 5. J Endocrinol Invest. 2024. PMID: 37668887 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
